Investigation préclinique

Membres

Didier Decaudin

Decaudin

Didier Decaudin Manager de plateforme Equipe LIP Retour à la liste

Publications clés

Année de publication : 2020

Decaudin Didier, Frisch Dit Leitz Estelle, Nemati Fariba, Tarin Malcy, Naguez Adnan, Zerara Mohamed, Marande Benjamin, Vivet-Noguer Raquel, Halilovic Ensar, Fabre Claire, Jochemsen Aart, Roman-Roman Sergio, Alsafadi Samar. (2020 Jan 9)

Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma.

European Journal of CancerEuropean Journal of Cancer : DOI : 10.1016/j.ejca.2019.12.012

Année de publication : 2018

Philippe De La Rochere, Silvia Guil-Luna, Didier Decaudin, Georges Azar, Sukhvinder S Sidhu, Eliane Piaggio (2018 Aug 6)

Humanized Mice for the Study of Immuno-Oncology.

Trends in immunology : 748-763 : DOI : S1471-4906(18)30125-X

Année de publication : 2017

Houcine Bougherara, Fariba Némati, André Nicolas, Gérald Massonnet, Martine Pugnière, Charlotte Ngô, Marie-Aude Le Frère-Belda, Alexandra Leary, Jérôme Alexandre, Didier Meseure, Jean-Marc Barret, Isabelle Navarro-Teulon, André Pèlegrin, Sergio Roman-Roman, Jean-François Prost, Emmanuel Donnadieu, Didier Decaudin (2017 Dec 17)

The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages.

Oncotarget : 99950-99965 : DOI : 10.18632/oncotarget.21556